Erasca hosts virtual investor event on updated ERAS-0015 Phase 1 data
ERAS•Erasca will host a virtual investor event on Nov. 20, 2026, focused on updated Phase 1 data for ERAS-0015 in RAS-mutant solid tumors; clinical data will also feature at a Barcelona symposium from Nov. 18-20.
1. Investor event and symposium
Erasca will host a virtual investor event on Nov. 20, 2026, at 8 a.m. Eastern Time, focused on updated Phase 1 data for ERAS-0015 in RAS-mutant solid tumors. Clinical data for ERAS-0015 will also feature at the 38th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Barcelona, Nov. 18-20; a poster will cover nonclinical combination data for ERAS-0015 and ERAS-4001.




